Search

everythinglearnresearchcommunity

for

Search:↓

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Certain drugs can cause lupus, stopping these drugs is the main treatment. NB-UVB phototherapy clears psoriasis faster when applied three times a week. Monoclonal antibodies and oral pimecrolimus are effective in treating psoriasis. Smoking and drinking are linked to psoriasis in men. No direct link between low iron and hair loss was found. Vaccines are effective against genital herpes and human papillomavirus type 16.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Skin problems are common in Bangladesh due to arsenic, prompt treatment of diabetic foot ulcers is crucial, maternal transmission causes most neonatal herpes, treatments for pediatric vasculitis are effective, the chickenpox vaccine works, more frequent UVB therapy helps psoriasis, certain jobs increase hand dermatitis risk, monoclonal antibodies treat psoriasis well, lifestyle affects psoriasis, alefacept improves psoriasis, imiquimod cream partially clears basal cell carcinoma, and iron may not help chronic hair loss.

Foreskin keratinocytes and SVK14 cells express certain cytochrome P450 enzymes, unlike hair follicle keratinocytes.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Merkel cell increase is specific to certain skin diseases, not general skin growth.

Paraproteinemic keratopathy can show eye symptoms before other signs of disease, needing careful treatment and long-term follow-up.

Type XII and XIV collagens help maintain hair follicle structure in bovine skin.

Desmocollin 1 and 3 have distinct patterns in human tissues, with Dsc1 in specific skin and hair layers and Dsc3 in various epithelial layers.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.

Different bovine tissues show varying types of cytokeratins.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Ocrelizumab helped control lupus in a pregnant patient, leading to the birth of a healthy baby.

Ocrelizumab may cause pancreatitis in some patients.

Different tissues in cows have different types of cytokeratins.

Sciellin is a protein that helps form protective layers in skin, hair, and nails.

Dupilumab may cause hair loss in some patients with severe atopic dermatitis.

The inner root sheath is crucial for hair follicle stability during the transition from growth to involution.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

A mycobacterial protein shares a similar region with a human skin protein, possibly affecting skin diseases.

Plet-1 protein helps hair follicle cells move and stick to tissues.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Different S100 proteins have specific roles in various parts of the hair follicle.

Ustekinumab treatment didn't prevent frontal fibrosing alopecia.

Mogamulizumab treatment in Sézary syndrome may cause skin issues and hair loss but can lead to a complete response.